{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:53:10Z","timestamp":1784688790619,"version":"3.55.0"},"reference-count":112,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2020,3,31]]},"DOI":"10.18632\/oncotarget.27532","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T13:57:16Z","timestamp":1586181436000},"page":"1186-1201","source":"Crossref","is-referenced-by-count":35,"title":["Origin and role of hepatic myofibroblasts in hepatocellular carcinoma"],"prefix":"10.18632","volume":"11","author":[{"given":"Betul Gok","family":"Yavuz","sequence":"first","affiliation":[{"name":"Department of Basic Oncology, Hacettepe University Cancer Institute, Ankara, Turkey"},{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Carmagnani","family":"Pestana","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehia I.","family":"Abugabal","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal M.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wolff","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Rashid","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham M.","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"name":"MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O.","family":"Kaseb","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"1","unstructured":"GLOBOCAN 2012: Liver cancer: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. https:\/\/publications.iarc.fr\/Databases\/Iarc-Cancerbases\/GLOBOCAN-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1.0-2012."},{"key":"2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of HCC: Consider the Population","volume":"47","author":"El-Serag","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"3","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Friedman","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular Carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer","volume":"12","author":"Schwabe","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3904\/kjim.2016.268","article-title":"Reversal of liver cirrhosis: current evidence and expectations","volume":"32","author":"Yim","year":"2017","journal-title":"Korean J Intern Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Subramanian","year":"2013","journal-title":"Lancet"},{"key":"9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"10","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1002\/cncr.29528","article-title":"Impact of hepatitis C virus eradication on hepatocellular carcinogenesis","volume":"121","author":"Chung","year":"2015","journal-title":"Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy","volume":"62","author":"Lampertico","year":"2015","journal-title":"J Hepatol"},{"key":"12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","article-title":"Matrix metalloproteinases in liver injury, repair and fibrosis","author":"Coito","year":"2015","journal-title":"Matrix Biol"},{"key":"13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Roeb","year":"2007","journal-title":"J Hepatol"},{"key":"14","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Glass","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/hep.28948","article-title":"The Origin of Fibrogenic Myofibroblasts in Fibrotic Liver","volume":"65","author":"Kisseleva","year":"2017","journal-title":"Hepatology"},{"key":"16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/aja.1001320404","article-title":"\u201cSternzellen\u201d in the liver: Perisinusoidal cells with special reference to storage of vitamin A","volume":"132","author":"Wake","year":"1971","journal-title":"Am J Anat"},{"key":"17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Schwabe","year":"2015","journal-title":"Nat Protoc"},{"key":"18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Friedman","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"19","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Wang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"20","doi-asserted-by":"publisher","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"Murray","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"21","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Schwabe","year":"2013","journal-title":"Nat Commun"},{"key":"22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13046-018-0965-2","article-title":"Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts","volume":"37","author":"Shi","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"23","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.2147\/CMAR.S176152","article-title":"A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma","volume":"10","author":"Li","year":"2018","journal-title":"Cancer Manag Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"e0121161","DOI":"10.1371\/journal.pone.0121161","article-title":"Establishment and characterization of rat portal myofibroblast cell lines","volume":"10","author":"Dranoff","year":"2015","journal-title":"PLoS One"},{"key":"25","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Weinberg","year":"2009","journal-title":"J Clin Invest"},{"key":"26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial-mesenchymal transition during tumor progression","volume":"17","author":"Beug","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Neilson","year":"2002","journal-title":"J Clin Invest"},{"key":"28","doi-asserted-by":"publisher","first-page":"23337","DOI":"10.1074\/jbc.M700194200","article-title":"Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition","volume":"282","author":"Kalluri","year":"2007","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/hep.23529","article-title":"Epithelial to Mesenchymal Transition in Liver Fibrosis: Here Today, Gone Tomorrow?","volume":"51","author":"Wells","year":"2010","journal-title":"Hepatology"},{"key":"30","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/hep.23368","article-title":"Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice","volume":"51","author":"Brenner","year":"2010","journal-title":"Hepatology"},{"key":"31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1053\/j.gastro.2010.05.005","article-title":"Genetic labeling does not detect epithelial-to-mesenchymal transition (EMT) of cholangiocytes in liver fibrosis in mice","volume":"139","author":"Kisseleva","year":"2010","journal-title":"Gastroenterology"},{"key":"32","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.7150\/jca.25775","article-title":"The Expression of FAP in Hepatocellular Carcinoma Cells is Induced by Hypoxia and Correlates with Poor Clinical Outcomes","volume":"9","author":"Zeng","year":"2018","journal-title":"J Cancer"},{"key":"33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41389-019-0140-4","article-title":"LXR\u03b1 limits TGF\u03b2-dependent hepatocellular carcinoma associated fibroblast differentiation","volume":"8","author":"Moustakas","year":"2019","journal-title":"Oncogenesis"},{"key":"34","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/hep.25742","article-title":"Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease","volume":"56","author":"Gaudio","year":"2012","journal-title":"Hepatology"},{"key":"35","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.stemcr.2016.11.002","article-title":"Myofibroblasts Derived from Hepatic Progenitor Cells Create the Tumor Microenvironment","volume":"7","author":"Suzuki","year":"2016","journal-title":"Stem Cell Reports"},{"key":"36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3978\/j.issn.2304-3881.2015.01.01","article-title":"Contribution of bone marrow-derived fibrocytes to liver fibrosis","volume":"4","author":"Kisseleva","year":"2015","journal-title":"Hepatobiliary Surgery and Nutrition"},{"key":"37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/978-1-59745-401-8_28","article-title":"Culture and analysis of circulating fibrocytes","volume":"135","author":"Bucala","year":"2007","journal-title":"Methods Mol Med"},{"key":"38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jhep.2006.04.014","article-title":"Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis","volume":"45","author":"Brenner","year":"2006","journal-title":"J Hepatol"},{"key":"39","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/labinvest.3700654","article-title":"The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses","volume":"87","author":"Mattoli","year":"2007","journal-title":"Lab Invest"},{"key":"40","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1164\/rccm.200810-1534OC","article-title":"Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis","volume":"179","author":"Kolb","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1189\/jlb.0906587","article-title":"Fibrocytes in lung disease","volume":"82","author":"Strieter","year":"2007","journal-title":"J Leukoc Biol"},{"key":"42","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5009\/gnl15226","article-title":"The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration","volume":"10","author":"Asahina","year":"2016","journal-title":"Gut and Liver"},{"key":"43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ydbio.2007.09.014","article-title":"Wt1 and retinoic acid signaling are essential for stellate cell development and liver morphogenesis","volume":"312","author":"Munoz-Chapuli","year":"2007","journal-title":"Dev Biol"},{"key":"44","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1073\/pnas.1214136110","article-title":"Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury","volume":"110","author":"Asahina","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"45","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jhep.2016.01.010","article-title":"Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers","volume":"64","author":"Asahina","year":"2016","journal-title":"J Hepatol"},{"key":"46","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/dvdy.24634","article-title":"Isolation of A Unique Hepatic Stellate Cell Population Expressing Integrin alpha8 from Embryonic Mouse Livers","volume":"247","author":"Asahina","year":"2018","journal-title":"Dev Dyn"},{"key":"47","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/cmi.2011.53","article-title":"Liver fibrosis: mechanisms of immune-mediated liver injury","volume":"9","author":"Wang","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"48","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nature04077","article-title":"Unravelling hepatitis C virus replication from genome to function","volume":"436","author":"Rice","year":"2005","journal-title":"Nature"},{"key":"49","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1038\/sj.cdd.4401163","article-title":"Hepatitis C and liver fibrosis","volume":"10","author":"Hahn","year":"2003","journal-title":"Cell Death Differ"},{"key":"50","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/hep.510230606","article-title":"Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa","volume":"23","author":"Ohta","year":"1996","journal-title":"Hepatology"},{"key":"51","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.gastro.2003.11.018","article-title":"Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells","volume":"126","author":"Brenner","year":"2004","journal-title":"Gastroenterology"},{"key":"52","doi-asserted-by":"publisher","first-page":"11329","DOI":"10.1074\/jbc.M410161200","article-title":"Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells","volume":"280","author":"Pinzani","year":"2005","journal-title":"J Biol Chem"},{"key":"53","doi-asserted-by":"publisher","first-page":"30649","DOI":"10.1038\/srep30649","article-title":"HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2","volume":"6","author":"Cirone","year":"2016","journal-title":"Sci Rep"},{"key":"54","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.ajpath.2011.12.039","article-title":"Hedgehog-Gli pathway activation during kidney fibrosis","volume":"180","author":"Humphreys","year":"2012","journal-title":"Am J Pathol"},{"key":"55","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00109-005-0680-2","article-title":"Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype","volume":"83","author":"Gress","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"56","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2741\/e184","article-title":"Circulating fibrocytes as a marker of liver fibrosis in chronic hepatitis C","volume":"2","author":"Cacopardo","year":"2010","journal-title":"Front Biosci (Elite Ed)"},{"key":"57","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.4049\/jimmunol.1600797","article-title":"Circulating and Exosome-Packaged Hepatitis C Single-Stranded RNA Induce Monocyte Differentiation via TLR7\/8 to Polarized Macrophages and Fibrocytes","volume":"198","author":"Szabo","year":"2017","journal-title":"J Immunol"},{"key":"58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B Virus Immunopathogenesis","volume":"13","author":"Ferrari","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"59","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3892\/ijmm.2012.1148","article-title":"HBV promotes the proliferation of hepatic stellate cells via the PDGF-B\/PDGFR-beta signaling pathway","volume":"30","author":"Jia","year":"2012","journal-title":"Int J Mol Med"},{"key":"60","first-page":"59","article-title":"Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2","volume":"8","author":"Liu","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"61","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bbrc.2013.04.098","article-title":"Hepatitis B virus e antigen induces activation of rat hepatic stellate cells","volume":"435","author":"Tien","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"62","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3892\/br.2017.894","article-title":"The evaluation of fibrotic effects of the hepatitis B virus pre-core in hepatic stellate cells","volume":"6","author":"Hosseini","year":"2017","journal-title":"Biomed Rep"},{"key":"63","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver Macrophages: Old Dogmas and New Insights","volume":"3","author":"Tacke","year":"2019","journal-title":"Hepatol Commun"},{"key":"64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12915-017-0392-4","article-title":"Tissue macrophages: heterogeneity and functions","volume":"15","author":"Pluddemann","year":"2017","journal-title":"BMC Biol"},{"key":"65","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis","volume":"50","author":"Tacke","year":"2009","journal-title":"Hepatology"},{"key":"66","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1189\/jlb.3A0614-280R","article-title":"Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis","volume":"97","author":"Nagy","year":"2015","journal-title":"J Leukoc Biol"},{"key":"67","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","article-title":"Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis","volume":"109","author":"Manning","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"Iredale","year":"2005","journal-title":"J Clin Invest"},{"key":"69","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cell.2014.11.018","article-title":"Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment","volume":"159","author":"Amit","year":"2014","journal-title":"Cell"},{"key":"70","doi-asserted-by":"publisher","first-page":"e000079","DOI":"10.1136\/bmjgast-2016-000079","article-title":"Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets","volume":"3","author":"Jia","year":"2016","journal-title":"BMJ Open Gastroenterol"},{"key":"71","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1001-9294(14)60076-6","article-title":"Progress of targeting transforming growth factor-beta1 small interfering RNA in liver fibrosis","volume":"29","author":"Yang","year":"2014","journal-title":"Chin Med Sci J"},{"key":"72","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.trsl.2015.04.002","article-title":"Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis","volume":"166","author":"Lee","year":"2015","journal-title":"Transl Res"},{"key":"73","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/hep.23894","article-title":"The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes","volume":"52","author":"Tacke","year":"2010","journal-title":"Hepatology"},{"key":"74","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: Physiology and role in liver diseases","volume":"66","author":"Rautou","year":"2017","journal-title":"J Hepatol"},{"key":"75","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/tgh.2018.04.05","article-title":"Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma","volume":"3","author":"Marchetti","year":"2018","journal-title":"Transl Gastroenterol Hepatol"},{"key":"76","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1309\/AJCP86PPBNGOHNNL","article-title":"Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection","volume":"131","author":"Tang","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"77","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1101\/gad.279737.116","article-title":"Carcinoma-associated fibroblasts: orchestrating the composition of malignancy","volume":"30","author":"Tlsty","year":"2016","journal-title":"Genes Dev"},{"key":"78","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1002\/ijc.25920","article-title":"Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice","volume":"129","author":"Wang","year":"2011","journal-title":"Int J Cancer"},{"key":"79","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/labinvest.2013.139","article-title":"Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model","volume":"94","author":"Wang","year":"2014","journal-title":"Lab Invest"},{"key":"80","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/onc.2016.273","article-title":"Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells","volume":"36","author":"Yang","year":"2016","journal-title":"Oncogene"},{"key":"81","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hep.26694","article-title":"Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma","volume":"59","author":"Cao","year":"2014","journal-title":"Hepatology"},{"key":"82","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1038\/oncsis.2016.7","article-title":"Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation","volume":"5","author":"Zhang","year":"2016","journal-title":"Oncogenesis"},{"key":"83","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2011.12.020","article-title":"Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO","volume":"318","author":"Chen","year":"2012","journal-title":"Cancer Lett"},{"key":"84","doi-asserted-by":"publisher","first-page":"8866","DOI":"10.18632\/oncotarget.6839","article-title":"Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"85","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia","volume":"376","author":"Kantarjian","year":"2017","journal-title":"N Engl J Med"},{"key":"86","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12876-015-0291-5","article-title":"Hepatic stellate cells: central modulators of hepatic carcinogenesis","volume":"15","author":"Henderson","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"87","doi-asserted-by":"publisher","first-page":"764981","DOI":"10.1155\/2014\/764981","article-title":"Hepatic Stellate Cell Coculture Enables Sorafenib Resistance in Huh7 Cells through HGF\/c-Met\/Akt and Jak2\/Stat3 Pathways","volume":"2014","author":"Ding","year":"2014","journal-title":"BioMed Research International"},{"key":"88","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1002\/hep.28835","article-title":"Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332\/alpha3 integrin axis recovery of focal adhesion kinase ubiquitination","volume":"64","author":"Giannelli","year":"2016","journal-title":"Hepatology"},{"key":"89","doi-asserted-by":"publisher","first-page":"36750","DOI":"10.1038\/srep36750","article-title":"Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids","volume":"6","author":"Seo","year":"2016","journal-title":"Sci Rep"},{"key":"90","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"Heidari","year":"2014","journal-title":"Cancer Cell"},{"key":"91","doi-asserted-by":"publisher","first-page":"741","DOI":"10.15252\/emmm.201607222","article-title":"Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin","volume":"9","author":"Augustin","year":"2017","journal-title":"EMBO Mol Med"},{"key":"92","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1515\/CCLM.2007.262","article-title":"New perspectives and strategy research biomarkers for hepatocellular carcinoma","volume":"45","author":"Debuire","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"93","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4137\/BIC.S34413","article-title":"Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma","volume":"8","author":"Lahiri","year":"2016","journal-title":"Biomark Cancer"},{"key":"94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1179299X16684640","article-title":"Biomarkers for Hepatocellular Carcinoma","volume":"9","author":"Jiang","year":"2017","journal-title":"Biomark Cancer"},{"key":"95","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.molmed.2018.02.006","article-title":"Genomic Profiling and Metabolic Homeostasis in Primary Liver Cancers","volume":"24","author":"Chen","year":"2018","journal-title":"Trends Mol Med"},{"key":"96","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1006\/scbi.2000.0321","article-title":"Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)","volume":"10","author":"Paterlini-Brechot","year":"2000","journal-title":"Semin Cancer Biol"},{"key":"97","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1038\/sj.onc.1206492","article-title":"Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene","volume":"22","author":"Brechot","year":"2003","journal-title":"Oncogene"},{"key":"98","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/jhep.2001.25172","article-title":"Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely \u201coccult\u201d?","volume":"34","author":"Paterlini-Br\u00e9chot","year":"2001","journal-title":"Hepatology"},{"key":"99","doi-asserted-by":"publisher","first-page":"11867","DOI":"10.1038\/s41598-017-11975-7","article-title":"Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma","volume":"7","author":"Nguyen","year":"2017","journal-title":"Sci Rep"},{"key":"100","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejso.2006.10.036","article-title":"Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma","volume":"33","author":"Lee","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"101","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1089\/aid.2012.0348","article-title":"Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems","volume":"29","author":"Samet","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"102","doi-asserted-by":"publisher","first-page":"764641","DOI":"10.1155\/2015\/764641","article-title":"Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family","volume":"2015","author":"Vannay","year":"2015","journal-title":"Mediators Inflamm"},{"key":"103","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13045-019-0742-5","article-title":"Immune cell therapy for hepatocellular carcinoma","volume":"12","author":"Kaneko","year":"2019","journal-title":"J Hematol Oncol"},{"key":"104","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/abbs\/gmq111","article-title":"Rapid determination of serological cytokine biomarkers for hepatitis B virus-related hepatocellular carcinoma using antibody microarrays","volume":"43","author":"Shen","year":"2011","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"105","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1155\/2013\/508023","article-title":"Rather than Rs1800796 Polymorphism, Expression of Interleukin-6 is Associated with Disease Progression of Chronic HBV Infection in a Chinese Han Population","volume":"35","author":"Yuan","year":"2013","journal-title":"Dis Markers"},{"key":"106","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1002\/ijc.24281","article-title":"High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B","volume":"124","author":"Chan","year":"2009","journal-title":"Int J Cancer"},{"key":"107","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1053\/j.gastro.2017.10.035","article-title":"Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals","volume":"154","author":"Boonstra","year":"2018","journal-title":"Gastroenterology"},{"key":"108","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3748\/wjg.v24.i11.1228","article-title":"Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions","volume":"24","author":"Abd Elkader","year":"2018","journal-title":"World J Gastroenterol"},{"key":"109","doi-asserted-by":"publisher","first-page":"412317","DOI":"10.1155\/2013\/412317","article-title":"Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients","volume":"2013","author":"Ibrahim","year":"2013","journal-title":"ISRN Hepatology"},{"key":"110","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/ijc.24720","article-title":"Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: An analysis based on gender differences","volume":"125","author":"Omata","year":"2009","journal-title":"Int J Cancer"},{"key":"111","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/1547691X.2012.758198","article-title":"Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?","volume":"10","author":"Schaalan","year":"2013","journal-title":"J Immunotoxicol"},{"key":"112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-5926-9-1","article-title":"Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4","volume":"9","author":"Esmat","year":"2010","journal-title":"Comp Hepatol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T20:48:10Z","timestamp":1591390090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":112,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,3,31]]}},"alternative-id":["27532","32284794"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27532","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]}}}